Filing Details
- Accession Number:
- 0001209191-10-004831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-26 12:00:00
- Reporting Period:
- 2010-01-22
- Filing Date:
- 2010-01-26
- Accepted Time:
- 2010-01-26 15:58:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1008848 | Acorda Therapeutics Inc | ACOR | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1272353 | David Lawrence | 15 Skyline Drive Hawthorne NY 10532 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-22 | 5,000 | $8.14 | 15,800 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-22 | 5,000 | $28.00 | 10,800 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2010-01-22 | 5,000 | $8.14 | 4,000 | $8.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,109 | 2005-08-03 | 2015-01-01 | No | 4 | M | Direct |
Footnotes
- Exercise and sale pursuant to a 10b5-1 plan.